View Cart (0 items)

Pharmaceutical

Glaxo to buy stake in South Africa''s Aspen

March 25, 2009
GlaxoSmithKline Plc plans to take a significant stake in Aspen Pharmacare Holdings Ltd to strengthen its partnership with the South African drugmaker, people familiar with the situation said, reported by
Read More

Biomedical and pharmaceutical sector to grow in Asia despite downturn

March 18, 2009
Asian economies are slowing down in tandem with the global recession. But Asia''s biomedical and pharmaceutical sector is using this period to gear itself up in preparation for an
Read More

Merck buying Schering-Plough in a $41.1 billion deal

March 9, 2009
Merck & Co. is buying Schering-Plough Corp. for $41.1 billion in stock and cash in a deal that gives the companies more firepower to compete in a drug industry facing
Read More

FDA says 3 deaths associated with Genentech drug

February 25, 2009
The Associated Press reports that three patients taking a Genentech drug are believed to have died of a rare brain infection, a known risk with the skin-clearing treatment, according to
Read More

Glaxo to cut prices for poor countries

February 16, 2009
The Associated Press reports that GlaxoSmithKline will cut drug prices to the 50 poorest countries in the world and use 20 percent of its profits from those countries to build
Read More

Sanofi Aventis wins EU OK to buy Zentiva

February 4, 2009
The European Commission said France''s Sanofi-Aventis SA must sell off medicines in Eastern Europe to win the EU’s antitrust approval to buy a Czech generic drug maker, the Associated
Read More

Free Web portal provides access to dynamic library of life science research

February 4, 2009
Sigma-Aldrich and Ingenuity Systems has launched Your Favorite Gene powered by Ingenuity, a Web-based biological search portal for exploring dynamic gene-based content (www.sigma-aldrich.com/yfg). Based on Ingenuity''s extensive library of research
Read More

Pfizer to buy Wyeth for $68 billion, cut jobs

January 26, 2009
Pfizer Inc. is buying rival drugmaker Wyeth in a $68 billion deal that will increase its revenue by 50 percent, solidify its No. 1 rank in the troubled industry and
Read More

Peanut butter probe focuses on Georgia plant

January 16, 2009
The Associated Press reports that federal food safety inspectors are focusing on a peanut-processing plant in Georgia that makes peanut butter for institutional use as the possible source of a
Read More

Lilly settles Zyprexa suit for $1.42 billion

January 16, 2009
Eli Lilly & Co. pleaded guilty to a charge that it illegally marketed the anti-psychotic drug Zyprexa for an unapproved use, and will pay $1.42 billion to settle civil suits
Read More